These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28526995)

  • 1. Two cycles of plasma rich in growth factors (PRGF-Endoret) intra-articular injections improve stiffness and activities of daily living but not pain compared to one cycle on patients with symptomatic knee osteoarthritis.
    Vaquerizo V; Padilla S; Aguirre JJ; Begoña L; Orive G; Anitua E
    Knee Surg Sports Traumatol Arthrosc; 2018 Sep; 26(9):2615-2621. PubMed ID: 28526995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial.
    Vaquerizo V; Plasencia MÁ; Arribas I; Seijas R; Padilla S; Orive G; Anitua E
    Arthroscopy; 2013 Oct; 29(10):1635-43. PubMed ID: 24075613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-Rich Plasma-Derived Growth Factor vs Hyaluronic Acid Injection in the Individuals with Knee Osteoarthritis: A One Year Randomized Clinical Trial.
    Raeissadat SA; Gharooee Ahangar A; Rayegani SM; Minator Sajjadi M; Ebrahimpour A; Yavari P
    J Pain Res; 2020; 13():1699-1711. PubMed ID: 32753945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Author Reply: Update the Dosing Frequency of Injections of PRGF-Endoret for the Treatment of Knee Osteoarthritis.
    Vaquerizo V
    Arthroscopy; 2024 Jul; 40(7):1956-1957. PubMed ID: 38537728
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyaluronate acid for treatment of chondromalacia patellae: a 52-week follow-up study].
    Zhang S; Jia M; Luo Y; Wang X; Shi Z; Xiao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jul; 39(7):791-796. PubMed ID: 31340911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunct treatment with ozone to enhance therapy of knee osteoarthritis: preliminary results.
    Valdenassi L; Chierchia M; Pandolfi S; Bellardi D; Chirumbolo S; Franzini M
    Clin Rheumatol; 2024 Jun; 43(6):2093-2101. PubMed ID: 38671261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Plasma Rich in Growth Factors for the Treatment of Knee Osteoarthritis.
    Gupta A
    Arthroscopy; 2024 Jul; 40(7):1956. PubMed ID: 38537723
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of plasma rich in growth factors for symptoms of diabetic neuropathy.
    Roman SJ; Broyer Z
    Endocrinol Diabetes Metab Case Rep; 2023 May; 2023(2):. PubMed ID: 37219507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of plasma rich in growth factors (PRGF) in stage 1 neurotrophic keratitis.
    Ghalibafan S; Osei KA; Amescua G; Sabater AL
    Eye (Lond); 2024 May; 38(7):1390-1391. PubMed ID: 38160214
    [No Abstract]   [Full Text] [Related]  

  • 10. Michel Lequesne (1924-2022).
    Bard H
    Joint Bone Spine; 2023 Jan; 90(2):105527. PubMed ID: 36706478
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of single injection of cross-linked sodium hyaluronate vs. three injections of high molecular weight sodium hyaluronate for osteoarthritis of the knee: a double-blind, randomized, multi-center, non-inferiority study.
    Ha CW; Park YB; Choi CH; Kyung HS; Lee JH; Yoo JD; Yoo JH; Choi CH; Kim CW; Kim HC; Oh KJ; Bin SI; Lee MC
    BMC Musculoskelet Disord; 2017 May; 18(1):223. PubMed ID: 28549436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis: A Review.
    Piuzzi NS; Chughtai M; Khlopas A; Harwin SF; Miniaci A; Mont MA; Muschler GF
    J Knee Surg; 2017 Sep; 30(7):627-633. PubMed ID: 28645132
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety of intra-articular injections for the treatment of knee osteoarthritis: a critical narrative review.
    Nguyen C; Rannou F
    Expert Opin Drug Saf; 2017 Aug; 16(8):897-902. PubMed ID: 28627937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell therapy in the treatment of hip osteoarthritis.
    Mardones R; Jofré CM; Tobar L; Minguell JJ
    J Hip Preserv Surg; 2017 Jul; 4(2):159-163. PubMed ID: 28630737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of intra-articular injection use after initiation of treatment in patients with knee osteoarthritis: data from the osteoarthritis initiative.
    Liu SH; Dubé CE; Driban JB; McAlindon TE; Eaton CB; Lapane KL
    Osteoarthritis Cartilage; 2017 Oct; 25(10):1607-1614. PubMed ID: 28627466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain sensation in human osteoarthritic knee joints is strongly enhanced by diabetes mellitus.
    Eitner A; Pester J; Vogel F; Marintschev I; Lehmann T; Hofmann GO; Schaible HG
    Pain; 2017 Sep; 158(9):1743-1753. PubMed ID: 28621703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of platelet concentration on clinical improvement in treatment of early stage-knee osteoarthritis with platelet-rich plasma concentrations.
    Dernek B; Kesiktas FN; Duymus TM; Aydin T; Isiksacan N; Diracoglu D; Aksoy C
    J Phys Ther Sci; 2017 May; 29(5):896-901. PubMed ID: 28603367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periarticular dextrose prolotherapy instead of intra-articular injection for pain and functional improvement in knee osteoarthritis.
    Rezasoltani Z; Taheri M; Mofrad MK; Mohajerani SA
    J Pain Res; 2017; 10():1179-1187. PubMed ID: 28553139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hylan GF-20 Viscosupplementation in the Treatment of Symptomatic Osteoarthritis of the Knee: Clinical Effect Survivorship at 5 Years.
    Boutefnouchet T; Puranik G; Holmes E; Bell KM
    Knee Surg Relat Res; 2017 Jun; 29(2):129-136. PubMed ID: 28545178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tapentadol prolonged release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled release-controlled studies.
    Lange B; von Zabern D; Elling C; Dubois C
    Curr Med Res Opin; 2017 Aug; 33(8):1413-1422. PubMed ID: 28537506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.